BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 19379551)

  • 1. [Deletions of derivative chromosome 9 in 138 patients with chronic myeloid leukemia].
    Wang L; Qian SX; Qiu HR; Wang R; Zhang SJ; Miao KR; Fan L; Xu W; Li JY
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2009 Apr; 17(2):281-4. PubMed ID: 19379551
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Karyotype analysis in 119 patients with chronic myeloid leukemia at blast crisis].
    Zhu Y; Li JY; Pan JL; Wu W; Qiu HR; Wu YF; Yang H; Zhang JF; Chen LJ; Xue YQ
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2006 Dec; 14(6):1074-8. PubMed ID: 17204167
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Detection of bcr/abl fusion gene and its derivative chromosome 9 deletions in CML by using home-made bcr/abl extra-signal probe].
    Lai YY; Feng L; Wang Z; Lü S; Dang H; Shi Y; He Q; Huang XJ
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2010 Feb; 18(1):199-203. PubMed ID: 20137147
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The prognostic significance of derivative chromosome 9 deletions in chronic myeloid leukemia].
    Wu W; Li JY; Shen YF; Cao XS; Qiu HR; Xu W
    Zhonghua Nei Ke Za Zhi; 2007 May; 46(5):386-8. PubMed ID: 17637307
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The application of fluorescence in situ hybridization in detecting chronic myeloid leukemia].
    Qiu HR; Miao KR; Wang R; Qiao C; Zhang JF; Zhang SJ; Qian SX; Xu W; Li JY
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2009 Apr; 26(2):207-10. PubMed ID: 19350518
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Study of deletion of derivative chromosome 9 in patients with Ph+ chronic myeloid leukemia].
    Wu W; Xue YQ; Wu YF; Pan JL; Shen J
    Zhonghua Xue Ye Xue Za Zhi; 2006 Mar; 27(3):183-6. PubMed ID: 16792921
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The negative prognostic impact of derivative 9 deletions in patients who received hydroxyurea treatment for chronic myelogenous leukemia in the chronic phase.
    Li JY; Xu W; Wu W; Zhu Y; Qiu HR; Zhang R; Zhang SJ; Qian SX
    Onkologie; 2008 Nov; 31(11):585-9. PubMed ID: 19145090
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic Implications of Derivative Chromosome 9 Deletions in Patients with Advanced-Stage Chronic Myelogenous Leukemia.
    Chandran RK; Geetha N; Sakthivel KM; Aswathy CG; Gopinath P; Nair JKKM; Sreedharan H
    J Environ Pathol Toxicol Oncol; 2018; 37(2):117-126. PubMed ID: 30055547
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A study on the incidence of ABL gene deletion on derivative chromosome 9 in chronic myelogenous leukemia by interphase fluorescence in situ hybridization and its association with disease progression.
    Lee DS; Lee YS; Yun YS; Kim YR; Jeong SS; Lee YK; She CJ; Yoon SS; Shin HR; Kim Y; Cho HI
    Genes Chromosomes Cancer; 2003 Jul; 37(3):291-9. PubMed ID: 12759927
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interphase fluorescence in situ hybridization studies for the detection of 9q34 deletions in chronic myelogenous leukemia: a practical approach to clinical diagnosis.
    Aoun P; Wiggins M; Pickering D; Foran J; Rasheed H; Pavletic SZ; Sanger W
    Cancer Genet Cytogenet; 2004 Oct; 154(2):138-43. PubMed ID: 15474149
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Molecular genetics in chronic myeloid leukemia with variant Ph translocation].
    Wu W; Li JY; Zhu Y; Qiu HR; Pan JL; Xu W; Chen LJ; Shen YF; Xue YQ
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2007 Aug; 24(4):470-3. PubMed ID: 17680547
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Deletions on der(9) chromosome in adult Ph-positive acute lymphoblastic leukemia occur with a frequency similar to that observed in chronic myeloid leukemia.
    Specchia G; Albano F; Anelli L; Storlazzi CT; Zagaria A; Mancini M; Cuneo A; Pane F; Foà R; Manolelli F; Liso V; Rocchi M
    Leukemia; 2003 Mar; 17(3):528-31. PubMed ID: 12646940
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Detection of Bcr/Abl gene rearrangement in chronic myelogenous leukemia patients by dual-color dual-fusion fluorescence in situ hybridization].
    Guo B; Zhu HL; Li SX; Lu XC; Fan H; Zhao DD; Han XP; DA WM
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2009 Apr; 17(2):261-5. PubMed ID: 19379547
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular cytogenetic study of derivative chromosome 9 deletion in chronic myeloid leukemia patients.
    Bennour A; Ouahchi I; Ben Youssef Y; Zaier M; Laatiri MA; Harrabi I; Meddeb B; Elloumi M; Khelif A; Saad A; Sennana H
    Med Oncol; 2012 Jun; 29(2):1151-60. PubMed ID: 21461967
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Coexistence of Philadelphia chromosome positive cells with and without der(9) deletion in a patient with chronic myelogenous leukemia.
    Xinh PT; Vu HA; Nghia H; Binh NT; Van Be T; Van Binh T; Tokunaga K; Sato Y
    Cancer Genet Cytogenet; 2006 Jan; 164(2):122-7. PubMed ID: 16434314
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The different signal patterns of two FISH probes in the FISH detection of Ph-positive leukemia and their clinical significance].
    Jiang H; Xue YQ; Pan JL; Zhang J; Dai HP; Wu YF; Wang Y; Shen J; Chen SN
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2010 Apr; 27(2):166-70. PubMed ID: 20376798
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genomic deletions on other chromosomes involved in variant t(9;22) chronic myeloid leukemia cases.
    Albano F; Specchia G; Anelli L; Zagaria A; Storlazzi CT; Buquicchio C; Roberti MG; Liso V; Rocchi M
    Genes Chromosomes Cancer; 2003 Apr; 36(4):353-60. PubMed ID: 12619159
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Variant Philadelphia chromosome identified by interphase fluorescence in situ hybridization (FISH) without evidence on G-banded karyotyping and metaphase FISH].
    Kim MK; Mun YC; Seong CM; Chung WS; Huh J
    Korean J Lab Med; 2010 Dec; 30(6):711-7. PubMed ID: 21157160
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Analysis and identification of variant Ph chromosome translocation in patients with chronic myelogenous leukemia by conventional cytogenetics and fluorescence in situ hybridization].
    Liu XP; Liu SH; Li CW; Bo LJ; Qin S; Dai Y; Qian LS
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2004 Jun; 12(3):298-303. PubMed ID: 15228654
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Heterogenic molecular basis for loss of ABL1-BCR transcription: deletions in der(9)t(9;22) and variants of standard t(9;22) in BCR-ABL1-positive chronic myeloid leukemia.
    Loncarevic IF; Römer J; Starke H; Heller A; Bleck C; Ziegler M; Fiedler W; Liehr T; Clement JH; Claussen U
    Genes Chromosomes Cancer; 2002 Jun; 34(2):193-200. PubMed ID: 11979553
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.